Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor

Authors:
  • PTPhuc Tran
    Phuc Tran
  • PTPhuc Tran
    Phuc Tran
  • MMMarialuisa Moccia
    Marialuisa Moccia
  • MMMarialuisa Moccia
    Marialuisa Moccia
  • XWXiuqi Wang
    Xiuqi Wang
  • XWXiuqi Wang
    Xiuqi Wang
  • ABAnnalisa Brescia
    Annalisa Brescia
  • ABAnnalisa Brescia
    Annalisa Brescia
  • GFGiorgia Federico
    Giorgia Federico
  • GFGiorgia Federico
    Giorgia Federico
  • NGNaresh Gunaganti
    Naresh Gunaganti
  • NGNaresh Gunaganti
    Naresh Gunaganti

Abstract
No abstract available
Funding Information
  • Arkansas Research Alliance
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Associazione Italiana per la Ricerca sul Cancro (2022ELYS5F)

This publication has 24 references indexed in Scilit: